424
Views
5
CrossRef citations to date
0
Altmetric
Review Articles

Drug repurposing strategies and key challenges for COVID-19 management

, , ORCID Icon, , ORCID Icon &
Pages 413-429 | Received 05 Oct 2021, Accepted 30 Nov 2021, Published online: 09 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nour Shaheen, Abdelrahman Mohamed, Almoatazbellah Attalla, Rehab Adel Diab, Sarya Swed, Abdulqadir J Nashwan, Ala’ Abdala Rababah, Mahmoud Tarek Hefnawy, Youssef Soliman, Omar Ahmed Abdelwahab, Mariam Tarek Desouki, Abdulrhman Khaity, Ahmed Shaheen, Abdelraouf Ramadan & Mostafa Meshref. (2022) Could the New BA.2.75 Sub-Variant Cause the Emergence of a Global Epidemic of COVID-19? A Scoping Review. Infection and Drug Resistance 15, pages 6317-6330.
Read now

Articles from other publishers (4)

Mohamed R. Elamin, Tarek A. Yousef & Amin O. Elzupir. (2023) Insight into Tyrosine-Containing Pharmaceuticals as Potential Inhibitors of SARS-CoV-2 3CLpro and NSP16: Structural Analysis, Docking Studies, Molecular Dynamics Simulations, and Density Functional Theory Investigations. Chemistry 5:2, pages 762-777.
Crossref
Smruti Rekha Rout, Gowtham Kenguva, Deepika Sharma, Amirhossein Sahebkar, Vidhu Aeri, Prashant Kesharwani & Rambabu Dandela. 2023. Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery. Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery 393 414 .
Tamás Kálai, Judit Erzsébet Pongrácz & Péter Mátyus. (2022) Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine. Chemistry 4:2, pages 216-258.
Crossref
Lu Lu, Jiale Qin, Jiandong Chen, Na Yu, Satoru Miyano, Zhenzhong Deng & Chen Li. (2022) Recent computational drug repositioning strategies against SARS-CoV-2. Computational and Structural Biotechnology Journal 20, pages 5713-5728.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.